Summary
The global IBS-C Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Major applications as follows:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major Type as follows:
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Catalent Pharmaceuticals Solutions
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Nestle
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Abbott Laboratories
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Synergy Pharmaceuticals
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Sucampo Pharmaceuticals
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Novartis Pharma Ag
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Astellas Pharmaceuticals
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Ardelyx, Inc
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Synthetic Biologics, Inc
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Teva Pharmaceutical Industries
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Bama-Geve, SLU
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Ferring BV
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 Ironwood Pharmaceuticals, Inc
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Salix Pharmaceuticals Ltd
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.14.4 Recent Development
3.15 Norgine B.V
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15.4 Recent Development
3.16 Prometheus Laboratories Inc
3.16.1 Company Information
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.16.4 Recent Development
3.17 Actavis Nordic A/S
3.17.1 Company Information
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.17.4 Recent Development
3.18 Albireo Pharma Inc
3.18.1 Company Information
3.18.2 Product & Services
3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.18.4 Recent Development
3.19 Yuhan Corp
3.19.1 Company Information
3.19.2 Product & Services
3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.19.4 Recent Development
3.20 Astrazeneca Plc
3.20.1 Company Information
3.20.2 Product & Services
3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.20.4 Recent Development
3.21 The Menarini Group
3.21.1 Company Information
3.21.2 Product & Services
3.21.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.22 Ono Pharmaceutical Co., Ltd
3.22.1 Company Information
3.22.2 Product & Services
3.22.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Hospital Pharmacies
4.1.1 Overview
4.1.2 Hospital Pharmacies Market Size and Forecast
4.2 Retail Pharmacies
4.2.1 Overview
4.2.2 Retail Pharmacies Market Size and Forecast
4.3 Online Pharmacies
4.3.1 Overview
4.3.2 Online Pharmacies Market Size and Forecast
5 Market by Type
5.By Linaclotide
5.1 Linaclotide
5.1.1 Overview
5.1.2 Linaclotide Market Size and Forecast
5.2 Lubiprostone
5.2.1 Overview
5.2.2 Lubiprostone Market Size and Forecast
5.3 Osmotic Laxatives
5.3.1 Overview
5.3.2 Osmotic Laxatives Market Size and Forecast
5.4 Stimulant Laxatives
5.4.1 Overview
5.4.2 Stimulant Laxatives Market Size and Forecast
5.5 Others
5.5.1 Overview
5.5.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
Fig Global IBS-C Drugs Market Size and CAGR 2013-2018 (Million USD)
Fig Global IBS-C Drugs Market Size and CAGR 2013-2018 (Volume)
Fig Global IBS-C Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global IBS-C Drugs Market Forecast and CAGR 2019-2025 (Volume)
Fig Hospital Pharmacies Market Size and CAGR 2013-2018 (Million USD)
Fig Hospital Pharmacies Market Size and CAGR 2013-2018 (Volume)
Fig Hospital Pharmacies Market Forecast and CAGR 2019-2025 (Million USD)
Fig Hospital Pharmacies Market Forecast and CAGR 2019-2025 (Volume)
Fig Retail Pharmacies Market Size and CAGR 2013-2018 (Million USD)
Fig Retail Pharmacies Market Size and CAGR 2013-2018 (Volume)
Fig Retail Pharmacies Market Forecast and CAGR 2019-2025 (Million USD)
Fig Retail Pharmacies Market Forecast and CAGR 2019-2025 (Volume)
Fig Online Pharmacies Market Size and CAGR 2013-2018 (Million USD)
Fig Online Pharmacies Market Size and CAGR 2013-2018 (Volume)
Fig Online Pharmacies Market Forecast and CAGR 2019-2025 (Million USD)
Fig Online Pharmacies Market Forecast and CAGR 2019-2025 (Volume)
Fig Linaclotide Market Size and CAGR 2013-2018 (Million USD)
Fig Linaclotide Market Size and CAGR 2013-2018 (Volume)
Fig Linaclotide Market Forecast and CAGR 2019-2025 (Million USD)
Fig Linaclotide Market Forecast and CAGR 2019-2025 (Volume)
Fig Lubiprostone Market Size and CAGR 2013-2018 (Million USD)
Fig Lubiprostone Market Size and CAGR 2013-2018 (Volume)
Fig Lubiprostone Market Forecast and CAGR 2019-2025 (Million USD)
Fig Lubiprostone Market Forecast and CAGR 2019-2025 (Volume)
Fig Osmotic Laxatives Market Size and CAGR 2013-2018 (Million USD)
Fig Osmotic Laxatives Market Size and CAGR 2013-2018 (Volume)
Fig Osmotic Laxatives Market Forecast and CAGR 2019-2025 (Million USD)
Fig Osmotic Laxatives Market Forecast and CAGR 2019-2025 (Volume)
Fig Stimulant Laxatives Market Size and CAGR 2013-2018 (Million USD)
Fig Stimulant Laxatives Market Size and CAGR 2013-2018 (Volume)
Fig Stimulant Laxatives Market Forecast and CAGR 2019-2025 (Million USD)
Fig Stimulant Laxatives Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Rosuvastatin Drugs Market:
The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...